APA-referens (7:e uppl.)

Rauch, H., Kitzberger, C., Janghu, K., Hawarihewa, P., Nguyen, N. T., Min, Y., . . . Kossatz, S. (2024). Combining [177Lu]Lu-DOTA-TOC PRRT with PARP inhibitors to enhance treatment efficacy in small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging, 51(13), 4099-4110. https://doi.org/10.1007/s00259-024-06844-1

Chicago-referens (17:e uppl.)

Rauch, Hartmut, et al. "Combining [177Lu]Lu-DOTA-TOC PRRT with PARP Inhibitors to Enhance Treatment Efficacy in Small Cell Lung Cancer." European Journal of Nuclear Medicine and Molecular Imaging 51, no. 13 (2024): 4099-4110. https://doi.org/10.1007/s00259-024-06844-1.

MLA-referens (9:e uppl.)

Rauch, Hartmut, et al. "Combining [177Lu]Lu-DOTA-TOC PRRT with PARP Inhibitors to Enhance Treatment Efficacy in Small Cell Lung Cancer." European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 13, 2024, pp. 4099-4110, https://doi.org/10.1007/s00259-024-06844-1.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.